Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Blood
|
May 11, 1999
Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis
S M Opal, J W Jhung, J C Keith, et al.
Critical Care Medicine
|
April 1, 1994
Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study
C J Fisher, M N Marra, J E Palardy, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1995
Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis
S M Opal, J E Palardy, J W Jhung, et al.
Public Health Reports (Washington, D.C. : 1974)
|
November 1, 1993
Investigation of a staphylococcal food poisoning outbreak in a centralized school lunch program
M S Richards, M Rittman, T T Gilbert, et al.
The Journal of Infectious Diseases
|
March 10, 2001
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis
A S Cross, S M Opal, H S Warren, et al.
The Journal of Infectious Diseases
|
June 1, 1996
Potential hazards of combination immunotherapy in the treatment of experimental septic shock
S M Opal, A S Cross, J W Jhung, et al.
The Journal of Infectious Diseases
|
November 7, 1998
Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocompromised animals
S M Opal, J W Jhung, J C Keith, et al.
Chest
|
January 1, 1986
Incidence of fever and bacteremia following transbronchial needle aspiration
M C Witte, S M Opal, J G Gilbert, et al.
The Journal of Infectious Diseases
|
June 1, 1990
Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa
S M Opal, A S Cross, N M Kelly, et al.
The Journal of Infectious Diseases
|
September 1, 1994
Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis
A K Bhattacharjee, S M Opal, J E Palardy, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Blood
|
May 11, 1999
Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis
S M Opal, J W Jhung, J C Keith, et al.
Critical Care Medicine
|
April 1, 1994
Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study
C J Fisher, M N Marra, J E Palardy, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1995
Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis
S M Opal, J E Palardy, J W Jhung, et al.
Public Health Reports (Washington, D.C. : 1974)
|
November 1, 1993
Investigation of a staphylococcal food poisoning outbreak in a centralized school lunch program
M S Richards, M Rittman, T T Gilbert, et al.
The Journal of Infectious Diseases
|
March 10, 2001
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis
A S Cross, S M Opal, H S Warren, et al.
The Journal of Infectious Diseases
|
June 1, 1996
Potential hazards of combination immunotherapy in the treatment of experimental septic shock
S M Opal, A S Cross, J W Jhung, et al.
The Journal of Infectious Diseases
|
November 7, 1998
Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocompromised animals
S M Opal, J W Jhung, J C Keith, et al.
Chest
|
January 1, 1986
Incidence of fever and bacteremia following transbronchial needle aspiration
M C Witte, S M Opal, J G Gilbert, et al.
The Journal of Infectious Diseases
|
June 1, 1990
Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa
S M Opal, A S Cross, N M Kelly, et al.
The Journal of Infectious Diseases
|
September 1, 1994
Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis
A K Bhattacharjee, S M Opal, J E Palardy, et al.
Page
of 11